| 0 (0%) | 12-26 20:16 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 16.77  |
1-year : | 18.2 |
| Resists | First : | 14.36 |
Second : | 15.59 |
| Pivot price | 13.39 |
|||
| Supports | First : | 12.37 |
Second : | 10.29 |
| MAs | MA(5) : | 12.95 |
MA(20) : | 13.67 |
| MA(100) : | 16.92 |
MA(250) : | 0 | |
| MACD | MACD : | -0.9 |
Signal : | -0.9  |
| %K %D | K(14,3) : | 5.5 |
D(3) : | 13.4 |
| RSI | RSI(14): 32.5 |
|||
| 52-week | High : | 22.25 | Low : | 3.99 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ OPRX ] has closed above bottom band by 7.0%. Bollinger Bands are 49.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 12.84 - 12.91 | 12.91 - 12.97 |
| Low: | 12.16 - 12.26 | 12.26 - 12.34 |
| Close: | 12.33 - 12.48 | 12.48 - 12.6 |
Fri, 26 Dec 2025
Can OPRX stock continue upward trend - Stock Price Divergence & Your Roadmap to 10x Returns Starts Here - bollywoodhelpline.com
Tue, 23 Dec 2025
OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story - Seeking Alpha
Mon, 22 Dec 2025
OptimizeRx (NASDAQ:OPRX) Insider Sells $18,751.88 in Stock - MarketBeat
Mon, 22 Dec 2025
Insider Sale: Chief Finance & Strat Officer of $OPRX Sells 1,388 Shares - Quiver Quantitative
Fri, 19 Dec 2025
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Mon, 17 Nov 2025
OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 19 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 15.5 (%) |
| Held by Institutions | 75 (%) |
| Shares Short | 1,740 (K) |
| Shares Short P.Month | 1,750 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.57 |
| Profit Margin | 0 % |
| Operating Margin | 7.8 % |
| Return on Assets (ttm) | 2.5 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 22.2 % |
| Gross Profit (p.s.) | 3.83 |
| Sales Per Share | 5.87 |
| EBITDA (p.s.) | 0.59 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 12 (M) |
| Levered Free Cash Flow | 11 (M) |
| PE Ratio | 1248 |
| PEG Ratio | 0 |
| Price to Book value | 1.89 |
| Price to Sales | 2.12 |
| Price to Cash Flow | 19.68 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|